SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Labriola Victoria – ‘3’ for 7/2/20 re: American Renal Associates Holdings, Inc.

On:  Thursday, 7/9/20, at 4:31pm ET   ·   For:  7/2/20   ·   Accession #:  1498068-20-87   ·   File #:  1-37751

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/09/20  Labriola Victoria                 3                      2:9K   American Renal Assocs Holdin… Inc American Renal Asso… Inc

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of        HTML      3K 
                Securities by an Insider --                                      
                wf-form3_159432664585141.xml/2.6                                 
 2: EX-24       Ex 24 - Victoria Labriola                           HTML      5K

‘3’   —   Initial Statement of Beneficial Ownership of Securities by an Insider — wf-form3_159432664585141.xml/2.6



        

This ‘3’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Initial Statement of Beneficial Ownership of Securities by an Insider — wf-form3_159432664585141.xml/2.6
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0206 </schemaVersion>
<documentType> 3 </documentType>
<periodOfReport> 2020-07-02 </periodOfReport>
<noSecuritiesOwned> 0 </noSecuritiesOwned>
<issuer>
<issuerCik> 0001498068 </issuerCik>
<issuerName> American Renal Associates Holdings, Inc. </issuerName>
<issuerTradingSymbol> ARA </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001817059 </rptOwnerCik>
<rptOwnerName> Labriola Victoria </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> C/O ARAH INC. </rptOwnerStreet1>
<rptOwnerStreet2> 500 CUMMINGS CENTER, SUITE 6550 </rptOwnerStreet2>
<rptOwnerCity> BEVERLY </rptOwnerCity>
<rptOwnerState> MA </rptOwnerState>
<rptOwnerZipCode> 01915 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> 0 </isDirector>
<isOfficer> 1 </isOfficer>
<isTenPercentOwner> 0 </isTenPercentOwner>
<isOther> 0 </isOther>
<officerTitle> VP and General Counsel </officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<nonDerivativeTable>
<nonDerivativeHolding>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 35701 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeHolding>
</nonDerivativeTable>
<derivativeTable>
<derivativeHolding>
<securityTitle>
<value> Stock Option (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 16.49 </value>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F1"/>
</exerciseDate>
<expirationDate>
<value> 2025-03-19 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 3970.0 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value> Stock Option (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 16.49 </value>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F2"/>
</exerciseDate>
<expirationDate>
<value> 2025-03-19 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 3968.0 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value> Stock Option (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 16.49 </value>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F3"/>
</exerciseDate>
<expirationDate>
<value> 2025-03-19 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 3968.0 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value> Stock Option (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 17.39 </value>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F4"/>
</exerciseDate>
<expirationDate>
<value> 2027-03-10 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 1450.0 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
<derivativeHolding>
<securityTitle>
<value> Stock Option (Right to Buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 10.19 </value>
</conversionOrExercisePrice>
<exerciseDate>
<footnoteId id="F5"/>
</exerciseDate>
<expirationDate>
<value> 2029-12-13 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 9139.0 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeHolding>
</derivativeTable>
<footnotes>
<footnote id="F1"> An option that vested in five equal annual installments beginning on March 19, 2016. </footnote>
<footnote id="F2"> An option that vested upon the attainment by Centerbridge Capital Partners, L.P. and certain of its affiliates (together, "Centerbridge") of both a 2.5 times return on investment ("MOIC") and a 20% internal rate of return ("IRR"). </footnote>
<footnote id="F3"> An option that vested upon the attainment by Centerbridge of both a 3.0 times MOIC and a 25% IRR. </footnote>
<footnote id="F4"> An option that vested in three equal annual installments beginning on March 10, 2018. </footnote>
<footnote id="F5"> An option that vests in three equal annual installments beginning on July 18, 2020. </footnote>
</footnotes>
<remarks> Exhibit 24 - Power of Attorney </remarks>
<ownerSignature>
<signatureName> /s/ Damien A. Grierson, by power of attorney </signatureName>
<signatureDate> 2020-07-09 </signatureDate>
</ownerSignature>
</ownershipDocument>


↑Top
Filing Submission 0001498068-20-000087   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 3:46:57.1am ET